Mode
Text Size
Log in / Sign up

Systematic review links neutrophil extracellular trap dysregulation to pregnancy complicationsWeb of White Blood Cells Linked to Pregnancy Risks

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret emerging links between NET dysregulation and pregnancy complications as hypothesis-generating.

A systematic review examined emerging evidence on the role of neutrophil extracellular trap (NET) dysregulation in pregnancy complications. The review focused on conditions including preeclampsia, gestational diabetes mellitus, preterm birth, recurrent pregnancy loss, systemic lupus erythematosus, and obstetric antiphospholipid syndrome. It proposed that excessive NET formation or defective clearance is strongly linked to the pathogenesis of these conditions, though the specific study designs, populations, and sample sizes of the included evidence were not reported.

The review also discussed the potential mechanistic roles of common obstetric medications—such as aspirin, metformin, low molecular weight heparin, hydroxychloroquine, and vitamin D—in relation to NET biology. No direct comparator groups, primary or secondary outcomes, or follow-up durations for the underlying studies were detailed. Consequently, no specific numerical results on efficacy or comparative effectiveness were presented.

Safety and tolerability data for the medications in this specific mechanistic context were not reported. Key limitations include the preliminary, narrative nature of the evidence, which is described as 'emerging.' The absence of reported study details, outcomes, and funding/conflict information restricts the ability to assess the strength of the associations. The practice relevance was not explicitly stated, and the review's findings should be interpreted as generating hypotheses for future research rather than providing direct clinical guidance.

Imagine your body fighting an infection while protecting a new life at the same time.

This delicate balance is key to a healthy pregnancy.

But sometimes, the immune system goes into overdrive.

During pregnancy, your body creates special web-like structures made of DNA.

Scientists call these neutrophil extracellular traps, or NETs.

They act like sticky nets that trap and kill germs.

This defense is vital for protecting the baby.

However, too many of these nets can cause serious problems.

When the body makes too many NETs, or cannot clean them up, trouble starts.

This excess activity is linked to preeclampsia, gestational diabetes, and preterm birth.

It also plays a role in recurrent pregnancy loss.

Many women face these challenges without clear answers.

Current treatments often manage symptoms but do not stop the root cause.

The surprising shift

Doctors used to think these webs were only good for fighting infection.

Now, research shows they can hurt the pregnancy if uncontrolled.

Think of it like a fire alarm that never stops ringing.

The system is trying to protect you, but it causes damage.

This new understanding changes how we view certain pregnancy complications.

It suggests that the problem is not just an infection.

It is often an immune system reaction that goes wrong.

What scientists didn't expect

The body uses a lock-and-key system to control these webs.

Normally, signals tell the cells when to stop making nets.

Sometimes, this signal fails, and the nets pile up.

This buildup blocks blood flow and causes inflammation.

Inflammation is the main driver of many pregnancy risks.

By stopping the nets, we might stop the damage.

This offers a fresh way to think about treatment.

Picture a traffic jam on a busy highway.

The NETs are like roadblocks that stop cars from moving.

In your body, these roadblocks stop blood from reaching the placenta.

Without good blood flow, the baby does not get enough oxygen.

This leads to conditions like preeclampsia and growth restriction.

The good news is that some common drugs may help clear the jam.

A recent review looked at how these webs form and cause harm.

Researchers studied many different pregnancy complications together.

They found that NETs are a common thread in these issues.

Several everyday medications might help clear these dangerous webs.

Drugs like aspirin and metformin showed promise in earlier studies.

Low molecular weight heparin also helps keep blood flowing smoothly.

Hydroxychloroquine and vitamin D may boost the body's cleanup crew.

These medicines do not just treat symptoms.

They may fix the underlying immune problem.

This doesn't mean this treatment is available yet.

You might wonder if you can take these drugs now.

The answer is not simple and depends on your specific case.

Some of these medicines are already used for other reasons.

Doctors might consider them for pregnancy complications in the future.

Talk to your doctor about your personal health history.

Do not start new medicines without professional advice.

Your care team knows your full medical picture best.

They can decide if these options fit your situation.

More research is needed to confirm these findings in humans.

Scientists must prove these drugs work safely for every patient.

It takes time to move from lab results to new guidelines.

We are closer to better treatments than we were before.

The goal is to help more families have healthy pregnancies.

Understanding these webs brings us one step closer to that goal.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Neutrophil extracellular traps (NETs) are fibrous, web-like structures released by activated neutrophils that consist of decondensed chromatin DNA coated with antimicrobial granular proteins. These structures play a dual role in host defense and pathology by effectively entrapping and eliminating pathogens. Under normal physiological conditions during pregnancy, appropriately regulated NET formation at the maternal–fetal interface functions as a crucial antimicrobial defense mechanism. However, emerging evidence indicates that excessive NET formation or defective clearance is strongly linked to the pathogenesis of several pregnancy complications such as preeclampsia, gestational diabetes mellitus, preterm birth, recurrent pregnancy loss, systemic lupus erythematosus, and obstetric antiphospholipid syndrome. This review systematically examines the regulatory mechanisms and pathophysiological contributions of NETs to these pregnancy complications. This review further explores the potential therapeutic mechanisms of common obstetric medications—including aspirin, metformin, low molecular weight heparin, hydroxychloroquine, and vitamin D-which may exert beneficial effects by suppressing NET formation or enhancing NET clearance.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.